SCYX Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
-100.0%
235.0K
0
-100.0%
18.6M
+5482.6%
334.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
0
-100.0%
235.0K
0
-100.0%
18.6M
+5482.6%
334.0K
Operating Expenses
9.8M
+21.9%
8.0M
-52.7%
16.9M
+108.5%
8.1M
-7.0%
8.7M
R&D
6.2M
+59.3%
3.9M
-68.5%
12.4M
+171.7%
4.5M
-16.6%
5.5M
SG&A
3.6M
-13.5%
4.1M
-10.2%
4.6M
+28.2%
3.6M
+8.9%
3.3M
Operating Income
-9761000
-25.5%
-7775000
+54.1%
-16939000
-261.0%
10.5M
+225.2%
-8405000
EBITDA
-9761000
-25.5%
-7775000
+54.1%
-16939000
-261.0%
10.5M
+225.2%
-8405000
Net Income
-8458000
-214.3%
7.4M
+134.7%
-21299000
-273.8%
12.3M
+242.7%
-8591000
EPS (Basic)
$-0.71
-212.7%
$0.63
+118.8%
$-3.36
-273.2%
$1.94
+240.6%
$-1.38
EPS (Diluted)
$-0.71
-212.7%
$0.63
+118.8%
$-3.36
-273.2%
$1.94
+240.6%
$-1.38
Shares (Diluted)
11.8M
+0.2%
11.8M
+85.6%
6.4M
+0.6%
6.3M
+1.5%
6.2M
SCYNEXIS (SCYX) — Financials